Scancell to go public after winning reverse merger bid for troubled Neuphoria
Scancell and Neuphoria have made their union official via a reverse merger that will result in a Nasdaq listing for Scancell and a resolution for Neuphoria’s shareholders after the biotech ended it…
fiercebiotech · 2mo ago

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

PUBLIC COMPANY

save

Scancell Holdings Plc

updated 4mo ago

community read0 votes

pipeline

marketed

phase 3

catalysts ytd

approvals ytd

recalls ytd

Pipeline(3)

pipeline depth3 products

1Preclinical2Phase 2

Small-Cell Lung Cancer

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

Active trials

phase2SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)active not recruitingn=173
phase2Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancerrecruitingn=168

🐶 Hiring Signal

No open roles indexed yet — view Scancell Holdings Plc jobs →

News

Scancell to go public after winning reverse merger bid for troubled Neuphoria
Scancell and Neuphoria have made their union official via a reverse merger that will result in a Nasdaq listing for Scancell and a resolution for Neuphoria’s shareholders after the biotech ended it…
fiercebiotech · 2mo ago

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

Scancell Holdings Plc

Pipeline(3)

📅 Upcoming

🕒 Recent(90d)

Active trials

News

comments(0)

Scancell Holdings Plc

Pipeline(3)

📅 Upcoming

🕒 Recent(90d)

Active trials

News

comments(0)

Upcoming

Recent(90d)

Upcoming

Recent(90d)